C
Captura Biopharma
Captura Biopharma - A Solution to Capturing Radioactive Heavy Metals
About Captura Biopharma
We are a group of Pharmaceutical Industry Executives, Military Vets, and Civic Volunteers dedicated to averting Public Health crisis related to Lead Poising, Radiation Poisoning, and other toxic heavy metals found in and around the environment in both the U.S. and developing nations. Captura is developing a drug called C2E2 for treatment of individuals who have been contaminated by highly radioactive compounds, either by accident or following a nuclear terrorism event. C2E2 is a ‘radionuclide decorporation agent’ that works by binding radioactive elements in the bloodstream and enhancing their elimination before they can be trapped inside the liver and bones where they can do maximum damage. Because C2E2 can be taken orally, it has significant advantages over existing radionuclide decorporation agents (e.g. DTPA), which must be administered by repeated intravenous injection in the presence of a trained caregiver, thereby reducing its utility. C2E2 can also be used to treat and remove gadolinium (used in MRI studies) and heavy metals, most notably lead, from the human body.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SPAC IPOOther financing | Aug 2022 | $100M | $224M | OceanTech Acquisitions I Corp | ↗ |
| LATE VCOther financing | Aug 2021 | $50M | $200M | Global Emerging Markets | ↗ |
Growth signals
Latest recorded traffic for Captura Biopharma is 670 monthly website visits, up 204.5% over the last three months. Captura Biopharma's team grew 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Captura Biopharma in the Little Rock ecosystem
The Captura Biopharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Global Emerging Markets
OceanTech Acquisitions I Corp
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Captura Biopharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Captura Biopharma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








